The second patient is a girl with FXS with a pathogenic variant in the PPP2R5D gene, while the third patient is a boy who has FXS and is simultaneously a carrier of a maternally inherited 2p25.3 deletion with low levels of MYT1L expression. The gene discussed is MYT1L; the disease is fragile X syndrome.